Skip to main content

Table 2 Meta-analysis and subgroup analysis of prevalence of HBV, HCV and among prisoners living with HIV

From: The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis

Variable

Number of studies

Pooled prevalence*

95% CI

I2 (%)

Heterogeneity (95% CI)

P value

Subgroup analysis for hepatitis B co-infection among prisoners living with HIV

 

WHO regions

Region of the Americas

3

5

3–7

0

1.75 (-3.37 to 6.87)

0.48

European of region

11

18

10–26

97.22

Western Pacific

2

27

23–31

0

South-East of Asia

1

3

1–11

0

Eastern Mediterranean region

5

3

0–5

24.16

African region

1

15

8–27

0

Study design

Cross-sectional

20

11

6–15

96.30

-6.28 (-33.45 to 20.88)

0.63

Cohort

3

5

4–7

0

Quality of study

High

10

8

3–13

94.02

-6.36 (-17.83 to 5.09)

0.26

Moderate

8

17

5–28

96.24

Low

5

18

9–28

97.74

Sample size

 < 50

6

21

0–43

96.64

-10.05 (-30.98 to 10.87)

0.32

 > 50

17

10

7–13

95.34

Year

 < 2005

5

38

16–59

99.04

-8.61 (-15.96 to -1.25)

0.02

2006–2010

8

6

4–8

34.60

2011–2015

4

3

0–6

30.21

 > 2015

6

5

3–8

54.80

Subgroup analysis for Hepatitis C co-infection among prisoners living with HIV

 

WHO regions

Region of the Americas

17

45

38–53

98.25

-6.81 (-11.28 to -2.34)

0.004

European of region

21

64

50–79

99.22

Western Pacific region

3

75

40–100

0

South-East of Asia region

2

83

74–91

0

Eastern Mediterranean region

7

83

73–93

92.69

Study design

Cross-sectional

46

62

52–72

99.40

-6.38 (-37.32 to 24.55)

0.68

Cohort

4

56

21–91

99.44

Quality of study

High

16

66

55–77

97.51

-2.78 (-14.58 to 9.01)

0.63

Moderate

24

54

39–69

99.60

Low

10

75

53–96

99.48

Sample size

 < 50

17

62

46–77

96.43

0.07 (-17.55 to 17.71)

0.99

 > 50

33

662

51–73

99.62

Year

 < 2005

11

61

36–86

99.45

-6.75 (-14.10 to 0.59)

0.20

2006–2010

13

71

53–90

99.61

2011–2015

13

71

56–86

97.15

 > 2015

13

42

25–59

99.46

  1. *Footnote: Prevalence was provided per 100 people